Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gene therapy

Showing results (11-20 of 4,883) with videos related to

Pageof 489
Sort By:
Gene Therapy|August 14, 2015
Development of novel AAV serotype 6 based vectors with selective tropism for human cancer cellsR Sayroo, D Nolasco, Z Yin, et al.
Gene Therapy|April 27, 2016
AAV-mediated transduction and targeting of retinal bipolar cells with improved mGluR6 promoters in rodents and primatesQ Lu, T H Ganjawala, E Ivanova, et al.
Gene Therapy|February 13, 2016
Treatment of colon cancer with oncolytic herpes simplex virus in preclinical modelsH Yang, T Peng, J Li, et al.
Gene Therapy|November 27, 2015
Helper-dependent adenoviral vectors for liver-directed gene therapy of primary hyperoxaluria type 1R Castello, R Borzone, S D'Aria, et al.
Gene Therapy|March 9, 2016
Axonal transport of AAV9 in nonhuman primate brainF Green, L Samaranch, H S Zhang, et al.
Gene Therapy|March 12, 2016
Adenovirus-mediated hAQP1 expression in irradiated mouse salivary glands causes recovery of saliva secretion by enhancing acinar cell volume decreaseL Y Teos, C-Y Zheng, X Liu, et al.
Gene Therapy|February 25, 2016
Intravesical treatment of advanced urothelial bladder cancers with oncolytic HSV-1 co-regulated by differentially expressed microRNAsK-X Zhang, Y Matsui, C Lee, et al.
Gene Therapy|January 28, 2016
Oncolytic vaccinia virus as a vector for therapeutic sodium iodide symporter gene therapy in prostate cancerD C Mansfield, J N Kyula, N Rosenfelder, et al.
Gene Therapy|April 20, 2016
Construction of minicircle DNA vectors capable of correcting familial hypercholesterolemia phenotype in a LDLR-deficient mouse modelX Hou, R Jiao, X Guo, et al.
Gene Therapy|July 15, 2015
Gene therapy with neurogenin3, betacellulin and SOCS1 reverses diabetes in NOD miceR Li, E Buras, J Lee, et al.
Pageof 489

Showing results (11-20 of 4,883) with videos related to

Sort By:
Pageof 489
Gene Therapy|August 14, 2015
Development of novel AAV serotype 6 based vectors with selective tropism for human cancer cellsR Sayroo, D Nolasco, Z Yin, et al.
Gene Therapy|April 27, 2016
AAV-mediated transduction and targeting of retinal bipolar cells with improved mGluR6 promoters in rodents and primatesQ Lu, T H Ganjawala, E Ivanova, et al.
Gene Therapy|February 13, 2016
Treatment of colon cancer with oncolytic herpes simplex virus in preclinical modelsH Yang, T Peng, J Li, et al.
Gene Therapy|November 27, 2015
Helper-dependent adenoviral vectors for liver-directed gene therapy of primary hyperoxaluria type 1R Castello, R Borzone, S D'Aria, et al.
Gene Therapy|March 9, 2016
Axonal transport of AAV9 in nonhuman primate brainF Green, L Samaranch, H S Zhang, et al.
Gene Therapy|March 12, 2016
Adenovirus-mediated hAQP1 expression in irradiated mouse salivary glands causes recovery of saliva secretion by enhancing acinar cell volume decreaseL Y Teos, C-Y Zheng, X Liu, et al.
Gene Therapy|February 25, 2016
Intravesical treatment of advanced urothelial bladder cancers with oncolytic HSV-1 co-regulated by differentially expressed microRNAsK-X Zhang, Y Matsui, C Lee, et al.
Gene Therapy|January 28, 2016
Oncolytic vaccinia virus as a vector for therapeutic sodium iodide symporter gene therapy in prostate cancerD C Mansfield, J N Kyula, N Rosenfelder, et al.
Gene Therapy|April 20, 2016
Construction of minicircle DNA vectors capable of correcting familial hypercholesterolemia phenotype in a LDLR-deficient mouse modelX Hou, R Jiao, X Guo, et al.
Gene Therapy|July 15, 2015
Gene therapy with neurogenin3, betacellulin and SOCS1 reverses diabetes in NOD miceR Li, E Buras, J Lee, et al.
Pageof 489